Non-Descent Of The Testis: An Overlooked Laparoscopic Finding UroToday.com - A manuscript by Dr. M. A. El Gohary on non-descent of the testes was published in the Journal of Pediatric Urology. The author shared cases of impalpable testes where the testes were located in a subrenal position. Laparoscopies were performed, and looping vas deferentia were noted to be going up the colonic gutter towards the kidney.
Source: www.medicalnewstoday.comBilcare GCS Expands Phase III Clinical Trial Service Capabilities As part of its commitment to providing its customers with comprehensive services that span the entire clinical supply chain, Bilcare Global Clinical Supplies, a leading single-source provider of clinical trial supplies and services, has enhanced its global Phase III capabilities.
Source: www.medicalnewstoday.comSeptember 13th Is National Childhood Cancer Awareness Day A pediatric bone cancer survivor who now is studying to become a pediatric hematologist/oncologist…a childhood leukemia survivor who has walked a mile in the shoes of the young cancer patients she now treats.
Source: www.medicalnewstoday.comAlte Biosciences Files Patent For New Inflammatory Bowel Disease Drugs - Unique Compositions Of Matter To Treat Gastrointestinal Disorders Alte Bioscience, Inc., a development stage pharmaceutical company, is pleased to announce the filing of a provisional patent for a new class of
drugs that may benefit patients with inflammatory bowel disease.
Source: www.medicalnewstoday.comFlu Vaccinations Begin On October 1 Maxim
Health Systems announced today that it will launch its annual influenza vaccination program. Starting on October 1, 2008, Maxim will begin providing flu shots nationwide through more than 25,000 public clinics. The company's Web site, http://www.FindAFluShot.
Source: www.medicalnewstoday.comLow Birth Weight Children Should Have Their Blood Pressure Checked Blood pressure in low-birth-weight children younger than 3 years of age not only can be measured but should be, researchers at UT Southwestern Medical Center have found. The findings appear in the September issue of Pediatrics.
Source: www.medicalnewstoday.comEmergent BioSolutions Receives $24 Million Development Contract From The DHH To Fund Continued Development Of Anthrax Monoclonal Antibody Emergent BioSolutions Inc. (NYSE:EBS) announced that it has received a contract from the Department of
Health and Human Services (HHS) for over $24.3 million to fund the further development of Emergent's anthrax monoclonal antibody AVP-21D9.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 AM
